A receptor for advanced glycosylation endproducts (AGEs) is colocalized with neurofilament-bound AGEs and SOD1 in motoneurons of ALS: immunohistochemical study

被引:24
作者
Chou, SM [1 ]
Han, CY
Wang, HS
Vlassara, H
Bucala, R
机构
[1] Calif Pacific Med Ctr, Norris ALS MDA Res Ctr, San Francisco, CA 94116 USA
[2] Picower Inst Med Res, Manhasset, NY 11030 USA
关键词
AGEs; ALS; IR;
D O I
10.1016/S0022-510X(99)00222-1
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Neurofilament (NF)-bound AGEs colocalize immunochemically with SOD1 in the motoneurons of patients with ALS. Among three types of AGE receptors reported in the human brain, AGE-R1 (oligosaccharyltransferase family) and AGE-R2 (substrate of protein kinase C) have been found in neurons, while AGE-R3 is restricted to glia. The present study investigates which of these receptors may be responsible for binding AGEs in the NF conglomerates of motoneurons. Immunostaining of paraffin sections from eight ALS patients (five sporadic and three familial) and three control cases was performed with antibodies directed against R1 and R2, in parallel with those against AGEs and SOD1. The sites of AGE-R1 immunoreactivity (IR) in motoneurons were in conformity to those of NF-associated AGE and SOD1 IRs. By contrast, the IR of R2 was negative in NF conglomerates. Negative R2 IR for NF conglomerates was outlined by surrounding coarse R2 immunopositive granules in the perikaryon. No IR for R1 or R2 was found in hyaline or Bunina inclusions. There was no extraneuronal expression of IR for AGE-R1 or AGEs in microglia or astroglia around the NF accumulation. The colocalization of AGE, AGE-R1, and SOD1 at NF conglomerates in motoneurons supports the notion that AGE-mediated oxidative stress and protein aggregation may be implicated in NF conglomeration and ALS pathogenesis. (C) 1999 Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:87 / 92
页数:6
相关论文
共 39 条
  • [1] Abe K, 1997, NEUROL RES, V19, P124
  • [2] Guamanian neurodegenerative disease: Are diabetes mellitus and altered humoral immunity clues to pathogenesis?
    Ahlskog, JE
    Petersen, RC
    Waring, SC
    EstebanSantillan, C
    Craig, UK
    Maraganore, DM
    Lennon, VA
    Kurland, LT
    [J]. NEUROLOGY, 1997, 48 (05) : 1356 - 1362
  • [3] AlAbed Y, 1997, DIABETES, V46, P271
  • [4] ROLE OF OXIDATIVE STRESS IN DEVELOPMENT OF COMPLICATIONS IN DIABETES
    BAYNES, JW
    [J]. DIABETES, 1991, 40 (04) : 405 - 412
  • [5] Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis
    Beal, MF
    Ferrante, RJ
    Browne, SE
    Matthews, RT
    Kowall, NW
    Brown, RH
    [J]. ANNALS OF NEUROLOGY, 1997, 42 (04) : 644 - 654
  • [6] BRETT J, 1993, AM J PATHOL, V143, P1699
  • [7] Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1
    Bruijn, LI
    Houseweart, MK
    Kato, S
    Anderson, KL
    Anderson, SD
    Ohama, E
    Reaume, AG
    Scott, RW
    Cleveland, DW
    [J]. SCIENCE, 1998, 281 (5384) : 1851 - 1854
  • [8] Bucala R, 1992, Adv Pharmacol, V23, P1
  • [9] BUCALA R, 1992, POSTTRANSLATIONAL MO, P53
  • [10] Advanced glycation endproducts in neurofilament conglomeration of motoneurons in familial and sporadic amyotrophic lateral sclerosis
    Chou, SM
    Wang, HS
    Taniguchi, A
    Bucala, R
    [J]. MOLECULAR MEDICINE, 1998, 4 (05) : 324 - 332